Licences of two more drug firms suspended by Indonesian food and drug agency

The companies had been ordered to pull the products and destroy remaining batches, she said, adding it also temporarily revoked their production licences.

Published On 2022-11-10 09:45 GMT   |   Update On 2022-11-10 10:10 GMT
Advertisement

Jakarta: Indonesia's food and drug agency said on Wednesday it had suspended the licences of two more local drug companies producing syrup-type medications, as authorities investigate the deaths of nearly 200 children due to acute kidney injury.

The Southeast Asian country temporarily banned sales of some syrup-based medications in October after it identified the presence in some products of ethylene glycol and diethylene glycol as possible factors for causing the illness.
The two ingredients are used in antifreeze and brake fluids and other industrial applications but also as a cheaper alternative in some pharmaceutical products to glycerine, a solvent or thickening agent in many cough syrups. They can be toxic and lead to acute kidney injury.
Penny K. Lukito, chief of the food and drugs agency (BPOM), told reporters the companies - PT Samco Farma and PT Ciubros Farma - used high levels of ethylene glycol and diethylene glycol in their products.
The companies had been ordered to pull the products and destroy remaining batches, she said, adding it also temporarily revoked their production licences.
Samco Farma and Ciubros Farma did not immediately respond to requests for comment.
Indonesian authorities were investigating raw material supply chains and screening processes to understand how an excess amount of the ingredients got into products, said Penny.
"The distribution line is long, from importers to some chemical product distributors and big traders until the raw ingredients reach the pharmaceutical industries," she said.
Earlier this week, BPOM suspended the distribution licences of three other companies making products that it said contained a high level of ethylene glycol and diethylene glycol.
Indonesia has been investigating the deaths in consultation with the World Health Organization (WHO) after a similar incident in Gambia this year, which has seen at least 70 deaths related to syrup medications made by India's Maiden Pharmaceuticals.
Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News